ReForm Biologics appoints Jim Sherblom to its Board of Directors as Chairman

– USA, MA –  ReForm Biologics today announced the appointment of Jim Sherblom to its board of directors as chairman to lead the shift in a strategy aiming to expand its focus to develop a new generation of bio-innovative biologic medicines in-house to improve patient access, safety, and convenience.…